pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Diclofenac Sodium
drug
save

diclofenac sodium SR

Marketedupdated 5mo ago
by Unique Pharmaceutical Laboratories Ltd
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval26 co-mentions · 13 sources
  • drugPennsaid19 co-mentions · 16 sources
  • drugdiclofenac19 co-mentions · 16 sources
  • drugDictor19 co-mentions · 16 sources
  • drugdiclofenac ER19 co-mentions · 16 sources
  • drugDICLOFENAC SODIUM19 co-mentions · 16 sources
  • drugdiclofenac sodium DR19 co-mentions · 16 sources
  • drugdiclofenac sodium ER19 co-mentions · 16 sources

all catalysts(0)

nothing on the calendar yet

Trials studying diclofenac sodium SR

  • phase3Counterpain PXM Versus Diclofenac Versus Piroxicamcompletedn=180
  • phase1Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.completedn=34
  • phase3A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Kneecompletedn=370
  • phase1Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participantscompletedn=74
  • phase4Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalpcompletedn=502
  • phase4A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalpactive not recruitingn=447
  • phase3Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)completedn=516
  • phase4A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)completedn=160

News(0)

no news has mentioned this drug yet

brand
Diclofenac Sodium
generic
diclofenac sodium
indication
Ankylosing Spondylitis (Bekhterev's Disease)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 8m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?